Sort
48,018 grants matching “immunotherapy”
Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular Probes
$472,826Vy M Dong · University Of California-Irvine · R35 · FY2024 · GM
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$472,823Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$472,806Elias Sayour · University Of Florida · R37 · FY2021 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$472,799Jlenia Guarnerio · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)
$472,782Richard W Roberts · University Of Southern California · R01 · FY2012 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$472,763Judith A. Varner · University Of California, San Diego · R01 · FY2021 · CA
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$472,759Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2023 · EB
Clinical Trials to Evaluate the Safety and Antiviral Effects of High Affinity Gag
$472,751Carl H. June · University Of Pennsylvania · U19 · FY2011 · AI
Regulation by Gammadelta T Cells of Autoimmune Uveitis (EAU)
$472,751Deming Sun · Doheny Eye Institute · R01 · FY2014 · EY
IMMUNOTHERAPY
$472,747Duke University · P01 · FY2000 · CA
Elucidating the Role of the Tumor Suppressor KEAP1 in Antitumor Immunity
$472,730Antonio Marzio · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Immune-based therapy against STEC intoxication and HUS
$472,682Saul R Tzipori · Tufts University Boston · R01 · FY2021 · AI
MNA Delivery of Neurokinin 1 Receptor Antagonists to Treat Atopic Dermatitis
$472,668Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AR
DEVELOPMENTAL FUNDS (Core-002)
$472,600Beverly Shriver Mitchell · Stanford University · P30 · FY2019 · CA
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$472,594Saar Gill · University Of Pennsylvania · P01 · FY2023 · CA
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$472,585Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Mechanisms of uveal melanoma dormancy and targeted therapy tolerance
$472,585Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
High Performance Magnetic Cell Sorting
$472,579Ohio State University · R01 · FY2003 · CA
Microbiome Function in Atopic Dermatitis
$472,527Richard L Gallo · University Of California, San Diego · U01 · FY2023 · AI
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles
$472,504Olivier Elemento · Weill Medical Coll Of Cornell Univ · U24 · FY2020 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles
$472,504Olivier Elemento · Weill Medical Coll Of Cornell Univ · U24 · FY2017 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles
$472,504Olivier Elemento · Weill Medical Coll Of Cornell Univ · U24 · FY2018 · CA
Microbiome Function in Atopic Dermatitis
$472,500Richard L Gallo · University Of California, San Diego · U01 · FY2020 · AI
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
$472,491Brock Clarke Christensen · Dartmouth College · R01 · FY2021 · CA
SOUTHWEST ONCOLOGY GROUP
$472,474University Of Rochester · U10 · FY2001 · CA